Hologic, Inc. (HOLX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Hologic, Inc. (HOLX)

Go deeper and ask any question about HOLX

Company Performance

Current Price

as of Sep 13, 2024

$81.15

P/E Ratio

27.69

Market Cap

$18.85B

Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Metrics

Overview

  • HQMarlborough, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerHOLX
  • Price$81.15+0.91%

Trading Information

  • Market Cap$18.85B
  • Float98.70%
  • Average Daily Volume (1m)1,257,816
  • Average Daily Volume (3m)1,542,206
  • EPS$2.95

Company

  • Revenue$3.99B
  • Rev Growth (1yr)2.74%
  • Net Income$194.50M
  • Gross Margin56.19%
  • EBITDA Margin33.24%
  • EBITDA$336.20M
  • EV$17.68B
  • EV/Revenue4.43
  • P/E27.69
  • P/S4.81